Our Partners
- URGO Group, is a French pharmaceutical company and a world expert and leader in the anatomy and physiology of the skin.
- URGO Group's medical care division is now the 2nd largest player on the wound-healing European market and has developed customized treatment & care protocols adapted to each wound.
- In 2012 based on a long and successful experience in aesthetic medicine with world famous brands, Urgo decided to launch its own first brand, Retix.C.
- Retix.C is a precursor in synergistic combinations of Retinoids and biologically active forms of Vitamin C, using ingredients that optimize their action, such as Growth Factors TGF-β2, Ferulic Acid, Peptides, Ceramides, and Ectoine.
Brands
Awards
Awarded $27.7 million in financial support, to help develop artificial skin for treating deep skin wounds and massive burns
The French government 2021
- Paves innovative cell free strategies for targeting incurable diseases via stem cell exosome.
- “One of three companies” that produce their own Exosome raw material. What characterizes Brexogen from the other two Exosome producers is its unique Cell Line.
- Brexogen Cell Line is originated from induced pluripotent stem cells, distinguishing it from other companies whose Cell Lines are derived from adult stem cells.
Brands
Awards
The Prime Minister’s Award at the Korea Business Technology R&D Expo
KIET2023The Minister’s Award for Korea Technology Commercialization Completion
Minister of Trade, Industry, and Energy2023Korea Challenge Grand Prize
SBA2023The Commissioner of Korean Intellectual Property Office Award on Invention Day
KIPA2023The Minister’s Award for the Promotion of Health Industry Health and Medical Technology Commercialization
Ministry of Health & Welfare2022Certifications
Certified for IP Management Enterprise
Korean Intellectual Property Office2024Designated as a Company with excellent technology
SCI Information Service2023INNOBIZ Company
Innovation Business Association2023Excellent Company for Job Invention Compensation
KIPO2022Company with Excellent technology
KoDATA2020
- I’LL GLOBAL Co., Ltd. took its first step in the cosmetics industry in 2004 with the idea of providing the best solution in the skincare and is continuing its research and development to provide the best quality products that can satisfy both skin experts and consumers through tHermoCEUTICAL brand.
- tHermoCEUTICAL is leading the global skincare market and is being recognized for its highest quality products by dermatologists and skin care experts from over than 20 countries including United States, Japan & China.
- tHermoCEUTICAL advancements are revolutionizing professional therapy with the Cellcubating System, a premium regenerating method. It uses DNA spicules to gently awaken skin cells, delivers active ingredients deeply, and incubates them for 24 hours for enhanced efficacy.
- tHermoCEUTICAL is pioneering the development of novel home care products, being the first to incorporate exosomes into their range. This innovation marks a significant advancement in the sector, leveraging the unique benefits of exosomes for unparalleled skincare at home.
